CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 189 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $48,000 | -87.6% | 11,784 | -52.2% | 0.00% | -100.0% |
Q4 2015 | $387,000 | +57.3% | 24,656 | +5.4% | 0.00% | +33.3% |
Q3 2015 | $246,000 | -64.8% | 23,384 | -15.5% | 0.00% | -57.1% |
Q2 2015 | $698,000 | +9.1% | 27,666 | +20.4% | 0.01% | 0.0% |
Q1 2015 | $640,000 | +50.9% | 22,975 | -1.0% | 0.01% | +40.0% |
Q4 2014 | $424,000 | +43.2% | 23,216 | +1.5% | 0.01% | +25.0% |
Q3 2014 | $296,000 | – | 22,864 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
LMR Partners LLP | 408,846 | $206,000 | 0.01% |